Annovis Bio (ANVS): Empery Asset Management, LP cut its ANVS stake below 5% (5.0%) 5.0%

5.0%

Stake

2.24M

Shares owned

Stake as of

Sep 30, 2026

Filed

Oct 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 14, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Oct 15, 20265% stakeEmpery Asset Management, LP reported a passive stake (13G) of 5.0%
2. Oct 29, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On October 29, 2026, Annovis Bio, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is no longer in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE’s Listed Company Manual due to the fact that the Company’s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the…”
3. Nov 3, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
4. Nov 4, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
5. Nov 5, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
6. Nov 6, 2026Insider · Largest insider buy since 2020Director purchased ~$5M of ANVS shares in the open market
7. Nov 13, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Schedule 13G

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Annovis Bio

For Annovis Bio, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANVS page.

How this filing works

• Schedule 13D vs 13G

Other disclosures at Annovis Bio

• SEC Form 4Nov 6, 2026
• SEC Form 4May 22, 2026
• SEC Form 4May 22, 2026
• SEC Form 4May 22, 2026
• SEC Form 4Apr 3, 2026
• SEC Form 4Dec 9, 2025

Everything OQRO holds on this company is on its ANVS page.